Browsing by Author "Pinto, Douglas Pereira"
Now showing items 1-9 of 9
-
Atazanavir Is a Competitive Inhibitor of SARS-CoV-2Mpro, Impairing Variants Replication In Vitro and In Vivo
Chaves, Otávio Augusto et al. | Date Issued: 2022 -
Cynomolgus monkeys are successfully and persistently infected with hepatitis E virus genotype 3 (HEV-3) after long-term immunosuppressive therapy
Gardinali, Noemi Rovaris et al. | Date Issued: 2017 -
Determination of levodopa in human plasma by high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS): application to a bioequivalence study
Martins, Heliana Figueiredo et al. | Date Issued: 2013 -
Development of a HPLC/MS/MS methodology for determining 3-O-methyldopa in human plasma and its application in a bioequivalence study
Martins, Heliana Figueiredo et al. | Date Issued: 2014Uma metodologia específica, simples e sensível baseado em HPLC/MS/MS foi desenvolvida e validada para realizar a determinação de 3-o-metildopa, o principal metabolito da dopamina, em plasma humano. A separação foi realizada ... -
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
Daher, André et al. | Date Issued: 2019 -
Pharmacological interaction of lopinavir/ritonavir 800/200 mg BID and rifampicin in subjects presenting tuberculosis with contraindication for an efavirenz containing antiretroviral regimen
Schmaltz, Carolina Arana Stanis et al. | Date Issued: 2014 -
Pharmacological profiling of JME-173, a novel mexiletine derivative combining dual anti-inflammatory/anti-spasmodic functions and limited action in Na+ channels
Pinto, Douglas Pereira et al. | Date Issued: 2020 -
Simple and rapid method determination for metformin in human plasma using high performance liquid chromatography tandem mass spectrometry: application to pharmacokinetic studies
Marques, Marlice A. Sípoli et al. | Date Issued: 2007